Dx-Rx Institute ApS: Financial statements 2020
CVR: 38196537
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Dx-Rx Institute ApS (CVR 38196537) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 22,767 and a net result of DKK 17,762 compared with DKK 3,602 the year before. That is an increase of 392.8% compared with the year before. Equity in the 2020 report amounted to DKK 67,297. The solvency ratio was 88.7%.
- Gross Profit
- DKK 22,767
- Profit/Loss
- DKK 17,762
- Equity
- DKK 67,297
- Total Assets
- DKK 75,855
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 23K | 18K | 67K | 0 |
| 2019 | - | 5K | 4K | 50K | 0 |
| 2018 | - | -13K | -10K | 46K | 0 |
Official annual report
How creditworthy is Dx-Rx Institute ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Dx-Rx Institute ApS has published its annual report for 2019. Gross profit came to DKK 4,620, and the net result was DKK 3,602.
About Dx-Rx Institute ApS
Dx-Rx Institute ApS was a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2016. The company has been dissolved on 30 May 2023. The company was registered under the industry Anden teknisk rådgivning. According to the 2022 annual report, the company had an average of 1 employee. In 2022, the company reported a gross profit of DKK -16,424 and a net result of DKK -16,470 compared with DKK 2,338 the year before. Equity in the 2022 report amounted to DKK 53,165.
